Genfit CEO: Don't count us out of NASH race By: CNBC.com News March 27, 2015 at 15:30 PM EDT The CEO of biotech company Genfit told CNBC that the markets are overreacting to the results of its NASH study. Read More >> Related Stocks: Deutsche Bank Ag Intercept Pharmaceuticals